Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment

OK Siddiqi, FL Ruberg - Trends in cardiovascular medicine, 2018 - Elsevier
The amyloidoses are a group of systemic diseases characterized by organ deposition of
misfolded protein fragments of diverse origins. The natural history of the disease …

Transthyretin cardiac amyloidosis: an update on diagnosis and treatment

H Yamamoto, T Yokochi - ESC heart failure, 2019 - Wiley Online Library
Transthyretin cardiac amyloidosis (ATTR‐CA) demonstrates progressive, potentially fatal,
and infiltrative cardiomyopathy caused by extracellular deposition of transthyretin‐derived …

Transthyretin (TTR) cardiac amyloidosis

FL Ruberg, JL Berk - Circulation, 2012 - Am Heart Assoc
The systemic amyloidoses are a family of diseases induced by misfolded or misassembled
proteins. Extracellular deposition of these proteins as soluble or insoluble cross-sheets …

Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group

AD Wechalekar, MT Cibeira, SD Gibbs, A Jaccard… - Amyloid, 2023 - Taylor & Francis
Background This guideline has been developed jointly by the European Society of
Haematology and International Society of Amyloidosis recommending non-transplant …

What is new in diagnosis and management of light chain amyloidosis?

G Palladini, G Merlini - Blood, The Journal of the American …, 2016 - ashpublications.org
Light chain (AL) amyloidosis is caused by a usually small plasma cell clone producing a
misfolded light chain that deposits in tissues. Survival is mostly determined by the severity of …

Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs

A Castaño, BM Drachman, D Judge, MS Maurer - Heart failure reviews, 2015 - Springer
Transthyretin-cardiac amyloidoses (ATTR-CA) are an underdiagnosed but increasingly
recognized cause of heart failure. Extracellular deposition of fibrillary proteins into tissues …

[HTML][HTML] Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships

F Bemporad, F Chiti - Chemistry & biology, 2012 - cell.com
The conversion of proteins from their native state to misfolded oligomers is associated with,
and thought to be the cause of, a number of human diseases, including Alzheimer's disease …

Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?

F aus dem Siepen, S Hein, S Prestel… - Clinical Research in …, 2019 - Springer
Background Carpal tunnel syndrome (CTS) and spinal canal stenosis can be frequently
observed in the medical history of patients with transthyretin amyloidosis (ATTR), both in the …

European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias

M Gavriatopoulou, P Musto, J Caers, G Merlini… - Leukemia, 2018 - nature.com
The introduction of novel agents in the management of multiple myeloma and related
plasma cell dyscrasias has changed our treatment approaches and subsequently the …

[HTML][HTML] Molecular mechanisms of cardiac amyloidosis

Y Saito, K Nakamura, H Ito - International journal of molecular sciences, 2021 - mdpi.com
Cardiac involvement has a profound effect on the prognosis of patients with systemic
amyloidosis. Therapeutic methods for suppressing the production of causative proteins have …